Previous Close | 166.31 |
Open | 170.10 |
Bid | 166.93 x 100 |
Ask | 167.18 x 200 |
Day's Range | 166.43 - 172.00 |
52 Week Range | 110.45 - 211.13 |
Volume | |
Avg. Volume | 500,565 |
Market Cap | 9.334B |
Beta (5Y Monthly) | 1.01 |
PE Ratio (TTM) | 618.70 |
EPS (TTM) | 0.27 |
Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 204.58 |
Repligen ( NASDAQ:RGEN ) First Quarter 2024 Results Key Financial Results Revenue: US$151.3m (down 17% from 1Q 2023...
Repligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript May 1, 2024 Repligen Corporation misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.29. Repligen Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, ladies and gentlemen, […]
Repligen's (RGEN) first-quarter 2024 earnings miss estimates while revenues beat the same.